Analyst Price Target is $15.50
▲ +291.41% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Aprea Therapeutics in the last 3 months. The average price target is $15.50, with a high forecast of $20.00 and a low forecast of $11.00. The average price target represents a 291.41% upside from the last price of $3.96.
Current Consensus is
Buy
The current consensus among 2 investment analysts is to buy stock in Aprea Therapeutics. This Buy consensus rating has held steady for over two years.